nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Non-cardiac chest pain—Docetaxel—head and neck cancer	0.0627	0.0701	CcSEcCtD
Telbivudine—Floxuridine—TYMS—head and neck cancer	0.0589	0.557	CrCbGaD
Telbivudine—Trifluridine—TYMS—head and neck cancer	0.0468	0.443	CrCbGaD
Telbivudine—Multi-organ failure—Docetaxel—head and neck cancer	0.0334	0.0373	CcSEcCtD
Telbivudine—Tenderness—Hydroxyurea—head and neck cancer	0.024	0.0268	CcSEcCtD
Telbivudine—Tenderness—Fluorouracil—head and neck cancer	0.0173	0.0193	CcSEcCtD
Telbivudine—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.0161	0.018	CcSEcCtD
Telbivudine—Laryngeal pain—Docetaxel—head and neck cancer	0.016	0.0178	CcSEcCtD
Telbivudine—Rhinorrhoea—Docetaxel—head and neck cancer	0.0134	0.015	CcSEcCtD
Telbivudine—Sepsis—Fluorouracil—head and neck cancer	0.0131	0.0146	CcSEcCtD
Telbivudine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0126	0.0141	CcSEcCtD
Telbivudine—Chest discomfort—Docetaxel—head and neck cancer	0.0123	0.0138	CcSEcCtD
Telbivudine—Neutropenia—Hydroxyurea—head and neck cancer	0.0123	0.0137	CcSEcCtD
Telbivudine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.0115	0.0128	CcSEcCtD
Telbivudine—Hypoaesthesia—Vinblastine—head and neck cancer	0.0115	0.0128	CcSEcCtD
Telbivudine—Pharyngitis—Vinblastine—head and neck cancer	0.0114	0.0128	CcSEcCtD
Telbivudine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0111	0.0124	CcSEcCtD
Telbivudine—Influenza like illness—Docetaxel—head and neck cancer	0.0106	0.0118	CcSEcCtD
Telbivudine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00979	0.0109	CcSEcCtD
Telbivudine—Muscular weakness—Fluorouracil—head and neck cancer	0.00965	0.0108	CcSEcCtD
Telbivudine—Sepsis—Docetaxel—head and neck cancer	0.00944	0.0106	CcSEcCtD
Telbivudine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00932	0.0104	CcSEcCtD
Telbivudine—Malaise—Vinblastine—head and neck cancer	0.00905	0.0101	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00879	0.00983	CcSEcCtD
Telbivudine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0085	0.0095	CcSEcCtD
Telbivudine—Discomfort—Vinblastine—head and neck cancer	0.00845	0.00944	CcSEcCtD
Telbivudine—Renal impairment—Docetaxel—head and neck cancer	0.0083	0.00928	CcSEcCtD
Telbivudine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00827	0.00924	CcSEcCtD
Telbivudine—Malaise—Hydroxyurea—head and neck cancer	0.00826	0.00923	CcSEcCtD
Telbivudine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00802	0.00897	CcSEcCtD
Telbivudine—Pain in extremity—Docetaxel—head and neck cancer	0.0079	0.00883	CcSEcCtD
Telbivudine—Migraine—Docetaxel—head and neck cancer	0.00777	0.00869	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00774	0.00866	CcSEcCtD
Telbivudine—Discomfort—Hydroxyurea—head and neck cancer	0.0077	0.00861	CcSEcCtD
Telbivudine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00753	0.00842	CcSEcCtD
Telbivudine—Pharyngitis—Fluorouracil—head and neck cancer	0.00751	0.0084	CcSEcCtD
Telbivudine—Paraesthesia—Vinblastine—head and neck cancer	0.00736	0.00823	CcSEcCtD
Telbivudine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00733	0.00819	CcSEcCtD
Telbivudine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00732	0.00818	CcSEcCtD
Telbivudine—Skin disorder—Hydroxyurea—head and neck cancer	0.00726	0.00812	CcSEcCtD
Telbivudine—Abdominal pain upper—Docetaxel—head and neck cancer	0.00721	0.00807	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00711	0.00795	CcSEcCtD
Telbivudine—Cramp muscle—Docetaxel—head and neck cancer	0.00711	0.00795	CcSEcCtD
Telbivudine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00706	0.0079	CcSEcCtD
Telbivudine—Pain—Vinblastine—head and neck cancer	0.00701	0.00783	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00697	0.00779	CcSEcCtD
Telbivudine—Feeling abnormal—Vinblastine—head and neck cancer	0.00675	0.00755	CcSEcCtD
Telbivudine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0067	0.00749	CcSEcCtD
Telbivudine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00658	0.00735	CcSEcCtD
Telbivudine—Abdominal pain—Vinblastine—head and neck cancer	0.00648	0.00724	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00645	0.00721	CcSEcCtD
Telbivudine—Fatigue—Hydroxyurea—head and neck cancer	0.00644	0.0072	CcSEcCtD
Telbivudine—Pain—Hydroxyurea—head and neck cancer	0.00639	0.00715	CcSEcCtD
Telbivudine—Neutropenia—Docetaxel—head and neck cancer	0.00638	0.00714	CcSEcCtD
Telbivudine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00616	0.00689	CcSEcCtD
Telbivudine—Renal failure—Docetaxel—head and neck cancer	0.00598	0.00669	CcSEcCtD
Telbivudine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00597	0.00667	CcSEcCtD
Telbivudine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00591	0.00661	CcSEcCtD
Telbivudine—Asthenia—Vinblastine—head and neck cancer	0.00588	0.00657	CcSEcCtD
Telbivudine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00576	0.00644	CcSEcCtD
Telbivudine—Myalgia—Fluorouracil—head and neck cancer	0.00561	0.00627	CcSEcCtD
Telbivudine—Chest pain—Fluorouracil—head and neck cancer	0.00561	0.00627	CcSEcCtD
Telbivudine—Diarrhoea—Vinblastine—head and neck cancer	0.00561	0.00627	CcSEcCtD
Telbivudine—Discomfort—Fluorouracil—head and neck cancer	0.00554	0.0062	CcSEcCtD
Telbivudine—Hepatitis—Docetaxel—head and neck cancer	0.00546	0.00611	CcSEcCtD
Telbivudine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00544	0.00608	CcSEcCtD
Telbivudine—Pharyngitis—Docetaxel—head and neck cancer	0.00542	0.00606	CcSEcCtD
Telbivudine—Dizziness—Vinblastine—head and neck cancer	0.00542	0.00606	CcSEcCtD
Telbivudine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00537	0.006	CcSEcCtD
Telbivudine—Asthenia—Hydroxyurea—head and neck cancer	0.00536	0.00599	CcSEcCtD
Telbivudine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00527	0.0059	CcSEcCtD
Telbivudine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00527	0.00589	CcSEcCtD
Telbivudine—Vomiting—Vinblastine—head and neck cancer	0.00521	0.00583	CcSEcCtD
Telbivudine—Headache—Vinblastine—head and neck cancer	0.00513	0.00574	CcSEcCtD
Telbivudine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00511	0.00572	CcSEcCtD
Telbivudine—Dizziness—Hydroxyurea—head and neck cancer	0.00494	0.00553	CcSEcCtD
Telbivudine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00492	0.00551	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0049	0.00548	CcSEcCtD
Telbivudine—Nausea—Vinblastine—head and neck cancer	0.00487	0.00544	CcSEcCtD
Telbivudine—Insomnia—Fluorouracil—head and neck cancer	0.00486	0.00544	CcSEcCtD
Telbivudine—Paraesthesia—Fluorouracil—head and neck cancer	0.00483	0.0054	CcSEcCtD
Telbivudine—Malnutrition—Docetaxel—head and neck cancer	0.00476	0.00532	CcSEcCtD
Telbivudine—Vomiting—Hydroxyurea—head and neck cancer	0.00475	0.00531	CcSEcCtD
Telbivudine—Dyspepsia—Fluorouracil—head and neck cancer	0.00473	0.00529	CcSEcCtD
Telbivudine—Rash—Hydroxyurea—head and neck cancer	0.00471	0.00527	CcSEcCtD
Telbivudine—Dermatitis—Hydroxyurea—head and neck cancer	0.00471	0.00526	CcSEcCtD
Telbivudine—Headache—Hydroxyurea—head and neck cancer	0.00468	0.00523	CcSEcCtD
Telbivudine—Dysgeusia—Docetaxel—head and neck cancer	0.00466	0.00521	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00464	0.00519	CcSEcCtD
Telbivudine—Back pain—Docetaxel—head and neck cancer	0.0046	0.00514	CcSEcCtD
Telbivudine—Pain—Fluorouracil—head and neck cancer	0.0046	0.00514	CcSEcCtD
Telbivudine—Muscle spasms—Docetaxel—head and neck cancer	0.00457	0.00511	CcSEcCtD
Telbivudine—Nausea—Hydroxyurea—head and neck cancer	0.00444	0.00496	CcSEcCtD
Telbivudine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00443	0.00496	CcSEcCtD
Telbivudine—Body temperature increased—Fluorouracil—head and neck cancer	0.00425	0.00475	CcSEcCtD
Telbivudine—Cough—Docetaxel—head and neck cancer	0.00415	0.00464	CcSEcCtD
Telbivudine—Arthralgia—Docetaxel—head and neck cancer	0.00405	0.00453	CcSEcCtD
Telbivudine—Myalgia—Docetaxel—head and neck cancer	0.00405	0.00453	CcSEcCtD
Telbivudine—Chest pain—Docetaxel—head and neck cancer	0.00405	0.00453	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00402	0.0045	CcSEcCtD
Telbivudine—Nervous system disorder—Docetaxel—head and neck cancer	0.00381	0.00426	CcSEcCtD
Telbivudine—Pruritus—Fluorouracil—head and neck cancer	0.00381	0.00425	CcSEcCtD
Telbivudine—Thrombocytopenia—Docetaxel—head and neck cancer	0.0038	0.00425	CcSEcCtD
Telbivudine—Skin disorder—Docetaxel—head and neck cancer	0.00377	0.00422	CcSEcCtD
Telbivudine—Diarrhoea—Fluorouracil—head and neck cancer	0.00368	0.00411	CcSEcCtD
Telbivudine—Dizziness—Fluorouracil—head and neck cancer	0.00356	0.00398	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00354	0.00395	CcSEcCtD
Telbivudine—Insomnia—Docetaxel—head and neck cancer	0.00351	0.00393	CcSEcCtD
Telbivudine—Paraesthesia—Docetaxel—head and neck cancer	0.00349	0.0039	CcSEcCtD
Telbivudine—Vomiting—Fluorouracil—head and neck cancer	0.00342	0.00382	CcSEcCtD
Telbivudine—Dyspepsia—Docetaxel—head and neck cancer	0.00342	0.00382	CcSEcCtD
Telbivudine—Rash—Fluorouracil—head and neck cancer	0.00339	0.00379	CcSEcCtD
Telbivudine—Dermatitis—Fluorouracil—head and neck cancer	0.00339	0.00379	CcSEcCtD
Telbivudine—Headache—Fluorouracil—head and neck cancer	0.00337	0.00377	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00335	0.00375	CcSEcCtD
Telbivudine—Fatigue—Docetaxel—head and neck cancer	0.00335	0.00374	CcSEcCtD
Telbivudine—Pain—Docetaxel—head and neck cancer	0.00332	0.00371	CcSEcCtD
Telbivudine—Feeling abnormal—Docetaxel—head and neck cancer	0.0032	0.00358	CcSEcCtD
Telbivudine—Nausea—Fluorouracil—head and neck cancer	0.00319	0.00357	CcSEcCtD
Telbivudine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00317	0.00355	CcSEcCtD
Telbivudine—Abdominal pain—Docetaxel—head and neck cancer	0.00307	0.00343	CcSEcCtD
Telbivudine—Body temperature increased—Docetaxel—head and neck cancer	0.00307	0.00343	CcSEcCtD
Telbivudine—Asthenia—Docetaxel—head and neck cancer	0.00279	0.00311	CcSEcCtD
Telbivudine—Pruritus—Docetaxel—head and neck cancer	0.00275	0.00307	CcSEcCtD
Telbivudine—Diarrhoea—Docetaxel—head and neck cancer	0.00266	0.00297	CcSEcCtD
Telbivudine—Dizziness—Docetaxel—head and neck cancer	0.00257	0.00287	CcSEcCtD
Telbivudine—Vomiting—Docetaxel—head and neck cancer	0.00247	0.00276	CcSEcCtD
Telbivudine—Rash—Docetaxel—head and neck cancer	0.00245	0.00274	CcSEcCtD
Telbivudine—Dermatitis—Docetaxel—head and neck cancer	0.00245	0.00273	CcSEcCtD
Telbivudine—Headache—Docetaxel—head and neck cancer	0.00243	0.00272	CcSEcCtD
Telbivudine—Nausea—Docetaxel—head and neck cancer	0.00231	0.00258	CcSEcCtD
